
...
By Hannah Millington
Health Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
A previously "hidden" subtype of Multiple Sclerosis (MS)—a condition that affects the brain and spinal cord—has been uncovered.
The distinct subtype exhibits "significant cognitive deficits with minimal motor impairment," as established in new research led by King's College London.
This MS subtype may often go undetected and untreated due to the lack of visible impairment it causes. However, the researchers present a new online assessment tool that's accessible and effective at scale.
Read More
Woman Shows Chronic Illness ‘Doesn’t Care’ About Dating—Shares Coping Tips3 min read

Christina Applegate Shares TMI Update on Health Amid ‘Scary’ MS Battle2 min read

Early Warning Signs For MS Discovered—Appear 15 Years Before Main Symptoms5 min read

"Our findings represent a significant step forward in our understanding of MS," said study author and King's digital healthcare researcher Annalaura Lerede in a statement.
"We found examples of people with this unrecognized subtype across all ages, no matter how long they'd had the disease. This reflects the risk of underestimating disability severity in this group throughout patients' disease courses.
"Assessing cognitive impairment is not a standard part of clinical practice. This research provides a viable and easily implemented means of testing cognitive function at home and could help vast numbers of people better understand their condition and direct in-person assessments to the people that need them the most."
The findings, the researchers say, hightlight the importance of providing cognitive assessments throughout the disease course for MS patients.

...
In the U.S., nearly one million people are living with MS, according to the National Multiple Sclerosis Society.
Cognitive impairment impacts 40–70 percent of patients with MS. It most commonly affects a person's ability to process information, their working memory and ability to sustain attention.
Despite its prevalence, the disorder is often unaddressed in treatment and neuropsychological assessments are not routine practice, the team highlighted.
While the condition cannot currently be cured, treatment can often help manage it, especially when right for the individual.

...
In their study, the researchers wanted to test the feasibility of using an online cognitive assessment platform—dubbed "Cognitron"—to measure and monitor cognitive impairment of people with MS.
The study involved 4,526 UK MS Register members over three stages.
Stage 1 worked with 3,066 patients to establish the feasibility of deploying Cognitron to people with MS from home and under unsupervised conditions. Results from this enabled the curation of a series of tasks sensitive to affected functions in MS.
The researchers built on this for stage 2, which replicated the findings from stage 1 in an independent sample and validated the bespoke Cognitron-MS tasks.
In their cohort from stage 2, the team discovered 307 people (26 percent) with the MS subtype.
"I think many others outside this study may have it," Lerede told Newsweek. "Cognition is an aspect of MS that is known to be affected sometimes with reported prevalence rates as high as 60–70 percent, but that is not usually assessed in routine clinical practice due to the impracticality and costs of assessing everyone with traditional methods.
"Additionally, cognitive symptoms are less evident compared to physical disability, so this aspect of MS tends to be hidden. I would not expect the presence of other symptoms-based subtypes, but I think the ones we are proposing can be further refined."
Lastly, in stage 3, the team's findings were evaluated against standard in-person assessments to ensure the platform's comparative validity and clinical utility.
Lerede said if the assessment tool was integrated into routine clinical practice it could "help identify and characterize the cognitive deficits people with MS have and monitor them over time."
Looking at the change in their cognitive function would "enable tailoring in-person assessments to who needs them the most as well as [help] understand the efficacy of different treatments also on this aspect of MS."
"Classic approaches to cognitive assessment are difficult to deploy in this sort of context due to the cost of supervised testing. By using a state of the art fully automated assessment approach we were able to test thousands of people with MS quickly, sensitively and at little cost," said study author and neuroscientist professor Adam Hampshire, also of King's, in a statement.
After the three stages, the team conducted further analysis to identify and characterize distinct symptom-based types of MS. This was what uncovered the prevalent subtype within the participants who experienced substantial cognitive deficits but did not experience the notable physical disabilities MS is more commonly associated with.
"MS symptoms are different for everyone and often invisible. But for too long, cognition has been overlooked and neglected, leaving people to struggle alone without access to the right treatment and services," said senior research communications manager at MS Society, Catherine Godbold, in a statement.
"This is the largest study on cognition in MS to date, and Cognitron-MS has the potential to transform how cognitive functioning is tested for people with MS. We're delighted that this could be rolled out to people with MS longitudinally in the future."
For now, Lerede can't say whether the new assessment could be used for pre-diagnosis too, but added the results from this study will get them closer to an answer.
The researchers now plan to use these tools to monitor changes in cognition in MS across time and determine which factors influence their development, how they relate to changes in the brain and how treatments for MS affect them.
Newsweek has contacted the researchers for additional comment.
Do you have a tip on a health story that Newsweek should be covering? Do you have a question about MS? Let us know via health@newsweek.com.
Reference
Lerede, A., Moura, A., Giunchiglia, V., Carta, E., Trender, W., Tuite-Dalton, K., Witts, J., Craig, E., Knowles, S., Rodgers, J., Cocco, E., Hellyer, P. J., Middleton, R., Nicholas, R., & Hampshire, A. (2025). Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairment. Nature Communications, 16. https://doi.org/10.1038/s41467-025-62156-4
View 0 Comments
Submit Correction
View Editorial & AI Guidelines